Biomarkers for Predicting the Occurrence and Progression of Atrial Fibrillation: Soluble Suppression of Tumorigenicity 2 Protein and Tissue Inhibitor of Matrix Metalloproteinase-1

Table 4

Multivariable predictors of atrial fibrillation progression among patients in the cohort.

Variates	Coef (95% CI)	OR	95% CI	value
Age (years)	0.020 (−0.002, 0.041)	1.020	0.998–1.042	0.069
Gender (M, %)	0.435 (−0.124,0.994)	1.544	0.883–2.701	0.128
LAd (mm)	0.089 (0.036, 0.143)	1.094	1.006–1.019	0.001
TIMP-1 (ng/ml)	0.013 (0.006, 0.019)	1.013	1.006–1.019	<0.001
sST2 (pg/ml)	0.082 (0.045, 0.120)	1.086	1.046–1.272	<0.001
BNP (pg/ml)	0.005 (0.002, 0.009)	1.005	1.002–1.009	0.002